Publication | Open Access

Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer

Prognostic BiomarkersEndothelial CellsMedicineBiomarker TargetImmunologyPathologyColorectal CancerImmune Checkpoint InhibitorVascular BiologyIndependent Predictive BiomarkersAdvanced Colorectal CancerOncologyRadiation OncologyTumor MicroenvironmentCancer Research